Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 37:1234-1238
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jhund, P. S.
Right arrow Articles by McMurray, J. J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jhund, P. S.
Right arrow Articles by McMurray, J. J. V.

Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure

Pardeep S. Jhund, BSca, Andrew P. Davie, BSc, MB, ChB, MRCPa and John J. V. McMurray, BSc, MB, MD, ChB, FRCP, FESC, FACCa

a Clinical Research Initiative in Heart Failure, University of Glasgow, Glasgow, United Kingdom



View larger version (21K):

[in a new window]
 
Figure 1 Mean (±SEM) percent change in venous capacitance in response to furosemide according to treatment group. Line with circles = placebo group; line with triangles = 75-mg aspirin group; line with squares = 300-mg aspirin group.

 


View larger version (18K):

[in a new window]
 
Figure 2 Mean (±SEM) percent change in venous capacitance in response to nitroglycerin (line with triangles).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement